Yuval Harry - Mar 22, 2024 Form 4 Insider Report for Hippo Holdings Inc. (HIPO)

Role
Chief Revenue Officer
Signature
/s /Stewart Ellis, Attorney-in-Fact for Yuval Harry
Stock symbol
HIPO
Transactions as of
Mar 22, 2024
Transactions value $
-$171,793
Form type
4
Date filed
3/26/2024, 04:10 PM
Previous filing
Mar 6, 2024
Next filing
May 3, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIPO Stock Options (Right to buy) Options Exercise $0 -3.86K -100% $0.00* 0 Mar 22, 2024 Common Stock 3.86K $8.50 Direct F6
transaction HIPO Stock Options (Right to buy) Options Exercise $0 -3.33K -100% $0.00* 0 Mar 22, 2024 Common Stock 3.33K $8.50 Direct F7
transaction HIPO Stock Options (Right to buy) Options Exercise $0 -6K -100% $0.00* 0 Mar 22, 2024 Common Stock 6K $4.00 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $17.25 USD to $17.28 USD; the price reported above reflects the weighted average sale price.
F2 This transaction was executed in multiple trades at prices ranging from $17.14 USD to $17.33 USD; the price reported above reflects the weighted average sale price.
F3 This transaction was executed in multiple trades at prices ranging from $17.17 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
F4 This transaction was executed in multiple trades at prices ranging from $17.12 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
F5 Includes 94,719 RSUs.
F6 The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of January 23, 2023.
F7 The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of May 13, 2023.
F8 The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of February 1, 2022.